Datar Genetics - About the company
Datar Genetics is an early stage company based in Nashik (India), founded in 1992 by Rajan Datar. It operates as a Provider of liquid biopsy-based cancer diagnostic test. Datar Genetics has raised $2.98M in funding from Alkemi Growth Capital, with a current valuation of ₹*****. The company has 471 active competitors, including 139 funded and 103 that have exited. Its top competitors include companies like Guardant Health, Natera and Myriad Genetics.
Company Details
Provider of liquid biopsy-based cancer diagnostic test. The products include trublood which is a non-invasive biopsy to check for malignancy, celldx for genome analysis of tumor, exacta for personalized treatment based on tumor analysis, and chemoscale to evaluate resistance to chemotherapy drugs by in-vitro analysis.
- Website
- datarpgx.com
- Email ID
- *****@datarpgx.com
- Phone Number
- +91 **********
- Registered Address
- F-8, D-Road, Ambad, Nashik, Nashik, Maharashtra, India, 422010
Key Metrics
Founded Year
1992
Location
Nashik, India
Stage
Early Stage
Total Funding
$2.98M in 1 round
Latest Funding Round
Post Money Valuation
₹***** as on Aug 26, 2024
Investors
Ranked
33rd among 471 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
40 as on Jun 30, 2026
Similar Companies
Legal entities associated with Datar Genetics
Datar Genetics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DATAR CANCER GENETICS PRIVATE LIMITED CIN: U01110MH1992PTC067409 , India, Active | Jun 24, 1992 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | - |
Sign up to download Datar Genetics' company profile
Datar Genetics's funding and investors
Datar Genetics has raised a total funding of $2.98M over 1 round. Its latest funding round was a Unattributed round on Aug 26, 2024 for ₹*****. 1 investor participated in its latest round. Datar Genetics has 3 institutional investors and 13 angel investors.
Here is the list of recent funding rounds of Datar Genetics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 26, 2024 | 1732270 | Unattributed | 4782089 | 1842035 | 8636594 | 8849260 |
View details of Datar Genetics's funding rounds and investors
Datar Genetics' founders and board of directors
Founder? Claim ProfileThe founders of Datar Genetics is Rajan Datar.
Here are the details of Datar Genetics' key team members:
- Rajan Datar: Founder of Datar Genetics.
Datar Genetics' Board of Directors
Datar Genetics's board has 2 active members. Swati Satish Deshpande and Sneha Datar are part of team.Here is the list of Datar Genetics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 13y 3m | |
pqhvpfk | Team | - | Current | 8y 5m |
yuecjfi | Independent board member | - | Past | 5y 2m |
fwjlimk | Independent board member | - | Past | 7y 5m |
ufrxifx | Independent board member | - | Past | 6y 4m |
View details of Datar Genetics's Founder profiles and Board Members
Datar Genetics' employee count trend
Datar Genetics has 40 employees as of Jun 26. Here is Datar Genetics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Datar Genetics's Competitors and alternates
Top competitors of Datar Genetics include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of Datar Genetics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Guardant Health 2012, Redwood City (United States), Public | Developer of digital sequencing technology for cancer detection | $557M | 79/100 | |
2nd | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 77/100 | |
3rd | Myriad Genetics 1991, United States, Public | Developer of molecular diagnostics and personalized medicine for cancer | - | 72/100 | |
4th | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | 71/100 | |
5th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 70/100 | |
6th | Online platform for genetic and diagnostic health testing that helps identify health risks | $67.6M | 70/100 | ||
7th | BillionToOne 2015, San Francisco (United States), Public | Provider of cell-free cancer liquid biopsy test | $389M | 69/100 | |
8th | Delfi Diagnostics 2019, Baltimore (United States), Series B | Provider of DNA sequencing for cancer detection | $332M | 68/100 | |
9th | Foresight Diagnostics 2020, Aurora (United States), Acquired | Developer of minimally-invasive liquid biopsy test for the detection of cancer | $104M | 66/100 | |
10th | Freenome Health 2014, United States, Series E | Provider of a deep learning platform for detecting circulating cancer-related markers | $1.35B | 66/100 | |
33rd | Datar Genetics 1992, Nashik (India), Early Stage | Provider of liquid biopsy-based cancer diagnostic test | $2.98M | 56/100 |
Looking for more details on Datar Genetics's competitors? Click here to see the top ones
Datar Genetics's Investments and acquisitions
Datar Genetics has made no investments or acquisitions yet.
Reports related to Datar Genetics
Here is the latest report on Datar Genetics's geography:
News related to Datar Genetics
Media has covered Datar Genetics for a total of 2 events in the last 1 year.
•
Datar Cancer Genetics Receives US FDA Clearance for CellDx-Tissue Genomic Profiling AssayBusinessFortNight•May 14, 2026•Datar Genetics
•
Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic AdvisorPR Newswire•Feb 11, 2025•Datar Genetics
•
•
Datar launches AI-powered platform for personalized cancer treatment.PR Newswire•Feb 03, 2025•Datar Genetics
•
•
•
Goodbody Health Partners with Datar to Offer Innovative Cancer ScreeningWebDisclosure•Jan 26, 2023•Goodbody Health, Datar Genetics
•
US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain TumorsAsian News International•Jan 03, 2023•Datar Genetics
•
Apollo Cancer Centre collaborates with Datar Cancer GeneticsIndiaMedToday•Jun 23, 2022•Apollo Hospitals, Datar Genetics, Apollo Hospitals Enterprise
•
Are you a Founder ?
FAQs about Datar Genetics
Explore our recently published companies
- LoopFood Hub - Lagos based, 2026 founded, Unfunded company
- IOGRU - New York City based, 2017 founded, Unfunded company
- Deumeu - 2024 founded, Unfunded company
- LAYERS - Barcelona based, 2012 founded, Unfunded company
- Fortitude Tech - Katy based, 2022 founded, Unfunded company
- iQual Tech - Bucharest based, 2009 founded, Unfunded company
